{'en': 'Asnadi and Patia Diabetes join in the fight against type 2 diabetes', 'es': 'ASNADI y Patia Diabetes se unen en la lucha contra la diabetes tipo 2'} Image

Asnadi and Patia Diabetes join in the fight against type 2 diabetes

fer's profile photo   06/27/2023 10:39 a.m.

The National Association of Dietists TSD ASNADI and Patia Diabetes Patia are pleased to announce the signature of an important collaboration agreement with the objective of joining efforts and resources to promote the prevention of type 2 diabetes and improve attention in the prevention of this diseaseThroughout the Spanish territory, in which type 2 diabetes is expected to be one of the usual dietitian consultations.The numbers do not stop growing year after year.

The agreement was signed by Raúl Gutiérrez, vice president of Asnadi, and Laureano Simón, CEO of Patia Diabetes, in an act that highlighted the commitment of both organizations in the fight against this chronic disease that affects a growing number of people in Spain.

Every day 1,100 people are diagnosed with type 2 diabetes in Spain.The cases of this disease could reach nine million affected in 2025, according to data provided Tuesday by the Spanish Diabetes Federation (Fede).And the diabetes -related health spending in Spain exceeds 8% of the total budget.

Improve results by joining knowledge and experience
The collaboration between Asnadi and Patia Diabetes has a clear objective: to generate a transformative impact on Spanish society, increasing the awareness and prevention of type 2 diabetes. To achieve this goal, they will focus on sensitizing the population about the importance of preventingThe complications associated with this condition, promoting healthy lifestyle habits such as a balanced diet and regular practice of physical exercise.In addition, this initiative will have recommendations based on the genotyped by Patia Diabetes, which will allow personalized guidelines in nutrition, physical activity and supplementation.

Together, Asnadi and Patia Diabetes work to promote a true transformation into the health of Spanish society, preventing type 2 diabetes in an integral way.

In addition, this agreement seeks to train dietitians associated with ASNADI in relation to the prevention of type 2 diabetes and their genetic predisposition, through awareness and educational programs.It is intended to provide professionals with the necessary tools to effectively address this disease and offer personalized attention to each patient.

As part of this agreement, a joint protocol will be established that allows to prevent type 2 diabetes and offer solutions to each patient, introducing tools for personalized prevention of the disease in the daily practice of dietitians.An outstanding aspect of this agreement is the creation of a community of certified dietists in the use of Predict Diabetes, Patia's genetic test, with the aim of promoting a more precise and efficient approach in the prevention of type 2 diabetes.

Both organizations are confident that this strategic collaboration will allow, through joint efforts, to achieve positive results in the fight against this growing disease.

"The collaboration between the different entities that deal with diabetes will grow with projects that are about to start up"

According to Patia Diabetes, this agreement has the ambitious objective of expanding to other areas of health.At the currentPeople with diabetes, with associations of dietitians-childish affiliated with FAPAE and other health services in Spain, both public and private.The objective is to comprehensively address this problem, involving various sectors and collaborating with entitiesrelevant in the field of health.

fer's profile photo
fer
06/27/2023 10:39 a.m.

@fer - Diabetes Tipo 1 desde 1.998 | FreeStyle Libre 3 | Ypsomed mylife YpsoPump + CamAPS FX | Sin complicaciones. Miembro del equipo de moderación del foro.
Co-Autor de Vivir con Diabetes: El poder de la comunidad online, parte de los ingresos se destinan a financiar el foro de diabetes y mantener la comunidad online activa.

  

Join the Discussion!

To participate in this thread, please register or log in.